Microproteins provide new playbook for Alzheimer's research
Researchers at the Salk Institute have developed a new microprotein atlas using human brain samples to better understand neurodegenerative diseases like Alzheimer's. The study identifies over 1,000 new microproteins, offering a new avenue for medical research.
Why it matters
This discovery could fundamentally change how scientists approach the molecular mechanisms of aging and neurodegeneration, potentially leading to new therapeutic targets.
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source A microglial cell within which an uncharacterized microprotein (orange) accumulates around its nucleus (blue). A new Salk Institute microprotein atlas can help determine what microproteins are expressed in microglia, and whether they are involved in the health or dysfunction of the critical brain cells. Credit: Salk Institute Scientists researching Alzheimer's disease and neurodegeneration have been playing a difficult game. Their scientific playbook has been limited by the available resources that, while capturing loads of genes, proteins and cells, have been missing something: microproteins.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in